Literature DB >> 23224374

Bioconversion of ginsenoside Rc into Rd by a novel α-L-arabinofuranosidase, Abf22-3 from Leuconostoc sp. 22-3: cloning, expression, and enzyme characterization.

Qing-Mei Liu1, Hae-Min Jung, Chang-Hao Cui, Bong-Hyun Sung, Jin-Kwang Kim, Song-Gun Kim, Sung-Taik Lee, Sun-Chang Kim, Wan-Taek Im.   

Abstract

A novel α-L-arabinofuranosidase (Abf22-3) that could biotransform ginsenoside Rc into Rd was obtained from the ginsenoside converting Leuconostoc sp. strain 22-3, isolated from the Korean fermented food kimchi. The gene, termed abf22-3, consisting of 1,527 bp and encoding a protein with a predicted molecular mass of 58,486 Da was cloned into the pMAL-c2x (TEV) vector. A BLAST search using the Abf22-3's amino acid sequence revealed significant homology to that of family 51 glycoside hydrolases. The over-expressed recombinant Abf22-3 in Escherichia coli BL21 (DE3) catalyzed the hydrolysis of the arabinofuranoside moiety attached to the C-20 position of ginsenoside Rc under optimal conditions of pH 6.0 and 30 °C. This result indicated that Abf22-3 selectively converts ginsenoside Rc into Rd, but did not catalyze the hydrolysis of glucopyranosyl groups from Rc or other ginsenosides such as Rb1 and Rb2. Over-expressed recombinant enzymes were purified by two steps with amylose-affinity and DEAE-cellulose chromatography and then characterized. The kinetic parameters for α-L-arabinofuranosidase showed apparent Km and Vmax values of 0.95 ± 0.02 μM and 1.2 ± 0.1 μmol min(-1) mg of protein(-1) against p-nitrophenyl-α-L-arabinofuranoside, respectively. Using a purified MBP-Abf22-3 (10 μg/ml), 0.1 % of ginsenoside Rc was completely converted to ginsenoside Rd within 20 min.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224374     DOI: 10.1007/s10482-012-9856-2

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  7 in total

Review 1.  Recent biotechnological progress in enzymatic synthesis of glycosides.

Authors:  Nguyen Huy Thuan; Jae Kyung Sohng
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-05       Impact factor: 3.346

Review 2.  Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd.

Authors:  Xiaoping Song; Lina Wang; Daidi Fan
Journal:  Biomolecules       Date:  2022-03-28

3.  An L213A variant of β-glycosidase from Sulfolobus solfataricus with increased α-L-arabinofuranosidase activity converts ginsenoside Rc to compound K.

Authors:  Ji-Hyeon Choi; Kyung-Chul Shin; Deok-Kun Oh
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

4.  Growth stimulation of Bifidobacterium from human colon using daikenchuto in an in vitro model of human intestinal microbiota.

Authors:  Kengo Sasaki; Daisuke Sasaki; Katsunori Sasaki; Yuto Nishidono; Akihiro Yamamori; Ken Tanaka; Akihiko Kondo
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

Review 5.  Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases.

Authors:  Jing Li; Qingxia Huang; Yao Yao; Peng Ji; E Mingyao; Jinjin Chen; Zepeng Zhang; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Lei Zhou; Xiangyan Li
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

6.  Characterization of a ginsenoside-transforming β-glucosidase from Paenibacillus mucilaginosus and its application for enhanced production of minor ginsenoside F₂.

Authors:  Chang-Hao Cui; Jin-Kwang Kim; Sun-Chang Kim; Wan-Taek Im
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

7.  Identification and characterization of a ginsenoside-transforming β-glucosidase from Pseudonocardia sp. Gsoil 1536 and its application for enhanced production of minor ginsenoside Rg2(S).

Authors:  Juan Du; Chang-Hao Cui; Sung Chul Park; Jin-Kwang Kim; Hong-Shan Yu; Feng-Xie Jin; Changkai Sun; Sun-Chang Kim; Wan-Taek Im
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.